Skip to main content
. 2024 Apr 24;12(5):451. doi: 10.3390/vaccines12050451

Figure 7.

Figure 7

Antibody titers (average of triplicate results) against various spike protein domains of SARS-CoV-2 variants in day 51 sera (21 days after the second dose). BEI convalescent sera were used as the reference sera. SIM/Moderna sera were used as positive controls.